These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6156757)

  • 1. Diagnostic significance of tumor markers.
    von Kleist SU
    Cancer Res; 1980 Aug; 40(8 Pt 2):2977-8. PubMed ID: 6156757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunoassays in oncology].
    Dressler J
    Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with the tumor marker Ca 19-9 in an unselected group of more than 300 tumor patients.
    Souchon R; Koppenhagen K; Souchon MF; Matthes M; Boese-Landgraf J; Fitzner R; Baer U
    Cancer Detect Prev; 1985; 8(1-2):101-9. PubMed ID: 3864534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of epithelial antigens in diagnosis and staging of breast cancer].
    Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
    Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers in breast cancer.
    Sulitzeanu D
    Isr J Med Sci; 1981; 17(9-10):865-8. PubMed ID: 7309474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CEA and related antigens as possible new tumor markers].
    Matsuoka Y
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T antigen and CEA; comparison between 2 tumor markers in breast cancer and malignant gynecologic neoplasms].
    Scheiffarth OF
    Arch Gynecol; 1979 Jul; 228(1-4):659-60. PubMed ID: 485546
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
    Fink LM; Clarke SM
    Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic applications of monoclonal antibodies to human cancer.
    Borowitz MJ; Stein RB
    Arch Pathol Lab Med; 1984 Feb; 108(2):101-5. PubMed ID: 6546490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic sensitivity, diagnostic specificity and predictive value of the determination of tumour markers.
    Wagener C
    J Clin Chem Clin Biochem; 1984 Dec; 22(12):969-79. PubMed ID: 6527105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current aspects of tumor immunology].
    Donat H; Schiller S
    Zentralbl Gynakol; 1986; 108(19):1153-63. PubMed ID: 2433851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
    von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
    Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International conference on human tumor markers. Biological basis and clinical relevance. Munich, Germany FR June 17-20, 1982. Abstracts.
    Cancer Detect Prev; 1982; 5(2):231-81. PubMed ID: 7127344
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of tumor markers in breast cancer].
    Konishi K; Karaki K; Watanabe K; Tsuda H; Konishi F
    Rinsho Byori; 1993 Oct; 41(10):1108-15. PubMed ID: 8254956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.